文献速递生殖医学

自然周期黄体颗粒细胞比刺激IVF周期黄体颗粒细胞更能维持活力、类固醇生成活性及LH受体表达

Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.
PubMed 文献 · Hum Reprod · 2019-01-01

该研究比较了自然周期与刺激IVF周期获取的黄体颗粒细胞(GC),发现刺激周期GC体外活力更低、LH受体及抗凋亡基因表达更低、凋亡更早,且不能维持雌二醇(E2)和孕酮(P4)产生;激动剂触发拮抗剂周期缺陷最显著。

要点

  • 自然周期GC体外活力88%,显著高于刺激周期(66%、64%、37%,P<0.01)。
  • 培养6天后自然周期GC活力74%,刺激周期仅48%、43%、22%(P<0.01)。
  • 激动剂触发拮抗剂周期GC的LH受体、VEGF及3β-HSD表达缺陷最明显。

核心结论

  • 刺激IVF周期黄体GC活力更低、凋亡更早、LH受体表达更低,且不能维持E2和P4产生,尤以激动剂触发拮抗剂周期为著。

研究设计与样本

  • 比较性转化研究,采用体外和体外模型,纳入154例IVF患者:自然周期22例,重组FSH和GnRH激动剂长方案44例,拮抗剂周期常规重组hCG触发46例,GnRH激动剂触发42例。
  • 黄体化GC体外维持培养长达6天。

主要发现

  • 自然周期GC体外活力88%,显著高于刺激周期(激动剂方案66%、拮抗剂hCG触发64%、拮抗剂激动剂触发37%,P<0.01)。
  • 培养6天结束时自然周期GC活力74%,刺激周期分别为48%、43%、22%(P<0.01)。
  • 刺激周期GC抗凋亡基因AKT-1和BCL2-L2 mRNA表达显著降低,促凋亡基因BAD、BAX和CASP3显著升高(长方案及拮抗剂hCG触发P<0.01,激动剂触发P<0.001)。
  • 刺激周期GC类固醇生成酶(stAR、SCC、3β-HSD、芳香化酶)和VEGF表达显著高于自然周期,培养前2天E2和P4产生显著更高,但第2天后活力及激素产生迅速下降,激动剂触发周期下降最剧烈。
  • 体外hCG处理激动剂触发周期部分细胞可改善活力、增加E2和P4产生,并上调BCL-L2及stAR、SCC、3B-HSD、LH受体、VEGF mRNA表达。

临床怎么用

  • 卵巢刺激方案及排卵触发方式与黄体GC活力和类固醇生成活性显著改变相关。
  • 刺激周期中3B-HSD、LH受体和VEGF表达下调导致类固醇产生受损,尤其激动剂触发周期,可能部分解释黄体期缺陷及需外源性支持。

局限性

  • 仅分析黄体化GC可能不能反映整个黄体在体内的存活和功能机制。
  • 取卵时获取的GC属于黄体期极早期,可能不具代表性。
  • hCG触发排卵的效应可能不等同于内源性LH触发。
  • 不同组患者临床特征可能存在差异,且因未利用卵母细胞,无法将刺激相关的黄体GC分子改变与临床结局关联。
  • 研究结果不能完全排除体内其他机制also导致刺激IVF周期黄体功能缺陷的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are there any differences in the molecular characteristics of the luteal granulosa cells (GC) obtained from stimulated versus non-stimulated (natural) IVF cycles that may help explain the defective luteal phase in the former? SUMMARY ANSWER: Luteal GC of stimulated IVF cycles, particularly those of agonist-triggered antagonist cycles, are less viable ex vivo, express LH receptor and anti-apoptotic genes at lower levels, undergo apoptosis earlier and fail to maintain their estradiol (E2) and progesterone (P4) production in comparison to natural cycle GC. WHAT IS KNOWN ALREADY: Luteal function is defective in stimulated IVF cycles, which necessitates P4 and/or hCG administration (known as luteal phase support) in order to improve clinical pregnancy rates and prevent miscarriage. The luteal phase becomes shorter and menstruation begins earlier than a natural cycle if a pregnancy cannot be achieved, indicative of early demise of corpus luteum (premature luteolysis). Supra-physiological levels of steroids produced by multiple corpora luteae in the stimulated IVF cycles are believed to inhibit LH release directly via negative feedback actions on the hypothalamic-pituitary-ovarian axis resulting in low circulating levels of LH and a defective luteal phase. We hypothesized that some defects in the viability and steroidogenic activity of the luteal GC of the stimulated IVF cycles might contribute to this defective luteal phase in comparison to natural cycle GC. This issue has not been studied in human before. STUDY DESIGN, SIZE, DURATION: A comparative translational research study of ex vivo and in vitro models of luteal GC recovered from IVF patients undergoing natural versus stimulated IVF cycles was carried out. Luteinized GC were obtained from 154 IVF patients undergoing either natural (n = 22) or stimulated IVF cycles with recombinant FSH and GnRH agonist (long) (n = 44), or antagonist protocol triggered conventionally either with recombinant hCG (n = 46) or with a GnRH agonist (n = 42). GC were maintained in vitro for up to 6 days. PARTICIPANTS/MATERIALS, SETTING, METHODS: Cellular viability (YO-PRO-1 staining), the expression of the steroidogenic enzymes, pro-apoptotic genes [Bcl-2-associated death promoter (BAD), Bcl-2-associated X protein (BAX) and Caspase-3 (CASP3)], anti-apoptotic genes [RAC-alpha serine/threonine-protein kinase (AKT-1) and Bcl-2-like protein 2 (BCL2-L2)], LH receptor, vascular endothelial growth factor (VEGF) (using real-time quantitative PCR at mRNA level and western blot immunoprecipitation assay at protein level) and in vitro E2 and P4 production (electrochemiluminescence immunoassay) were compared in GC among the groups. MAIN RESULTS AND THE ROLE OF CHANCE: Natural cycle GC were significantly more viable ex vivo (88%) compared to their counterparts of the stimulated IVF cycles (66, 64 and 37% for agonist and antagonist cycles triggered with hCG and GnRH agonist respectively, P < 0.01). They were also more capable of maintaining their vitality in culture compared to their counterparts from the stimulated IVF cycles: at the end of the 6-day culture period, 74% of the cells were still viable whereas only 48, 43 and 22% of the cells from the agonist and antagonist cycles triggered with hCG and agonist respectively, were viable (P < 0.01). The mRNA expression of anti-apoptotic genes (AKT-1 and BCL2-L2) was significantly lower, while that of pro-apoptotic genes (BAD, BAX and CASP3) was significantly higher in the stimulated cycles, particularly in the agonist-triggered antagonist cycles, compared to natural cycle GC (P < 0.01 for long protocol and antagonist hCG trigger, P < 0.001 for agonist trigger). The expression of steroidogenic enzymes (stAR, SCC, 3β-HSD and aromatase) and VEGF was significantly higher in the agonist and hCG-triggered antagonist cycles compared to natural cycle GC. Therefore, in vitro E2 and P4 production in cells from the stimulated IVF cycles was significantly higher than their counterparts obtained from the natural cycles in the first 2 days of culture. However, after Day 2, their viability and hormone production began to decline very rapidly with the most drastic decrease being observed in the agonist-triggered cycles. By contrast, natural cycle GC maintained their viability and produced E2 and P4 in increasing amounts in culture up to 6 days. In vitro P production and the mRNA and protein expression of LH receptor, VEGF and 3β-HSD were most defective in the agonist-triggered antagonist cycles compared to natural and agonist and hCG-triggered antagonist cycles. In vitro hCG treatment of a subset of the cells from the agonist-triggered cycles improved their viability, increased E2 and P4 production in vitro and up-regulated the mRNA expression of anti-apoptotic gene BCL-L2 together with steroidogenic enzymes stAR, SCC, 3B-HSD, LH receptor and VEGF. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: The limitations include analysis of luteinized GC only might not reflect the in vivo mechanisms involved in survival and function of the whole corpus luteum; GC recovered during oocyte retrieval belong to a very early stage of the luteal phase and might not be representative; effects of ovulation triggered with hCG may not equate to the endogenous LH trigger; the clinical characteristics of the patients may vary among the different groups and it was not possible to correlate stimulation-related molecular alterations in luteal GC with the clinical outcome, as no oocytes have been utilized yet. Therefore, our findings do not conclusively rule out the possibility that some other mechanisms in vivo may also account for defective luteal function observed in stimulated IVF cycles. WIDER IMPLICATIONS OF THE FINDINGS: Ovarian stimulation is associated with significant alterations in the viability and steroidogenic activity of luteal GC depending on the stimulation protocol and mode of ovulation trigger. Reduced survival and down-regulated expression of 3B-HSD, LH receptor and VEGF leading to compromised steroid production in stimulated cycles, and particularly in the agonist-triggered cycles, may at least in part help explain why the luteal phase is defective and requires exogenous support in these cycles. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the School of Medicine, the Graduate School of Health Sciences of Koc University and Koç University Research Center for Translational Medicine (KUTTAM), equally funded by the Republic of Turkey Ministry of Development Research Infrastructure Support Program. All authors declare no conflict of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bildik G, Akin N, Seyhan A, et al. Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles. Hum Reprod. 2019. PMID: 30520979. doi:10.1093/humrep/dey353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。